The increasing cancer incidence, technological advances and the advantages IORT provides over conventional radiation therapy are key factors driving the growth of the global intraoperative radiation therapy market .

Global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. Intraoperative radiotherapy offers advantages such as high precision, better cosmetic outcomes, greater patient comfort, and cost-effectiveness.

Recent Developments

• Elekta AB launched Geneva, a universal gynecological applicator for brachytherapy.
• Varian acquired Cancer Treatment Services International (CTSI), a US-based oncology solutions division that provides cancer care professional services to healthcare providers worldwide. The acquisition expanded Varian's access to technology-driven cancer care

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083

The Electron IORT segment to account for the largest share of the intraoperative radiation therapy market, by technology

The electron IORT segment is expected to account for the largest share of the intraoperative radiation therapy market. IOERT is a suitable option for patients with locally advanced or recurrent cancer such as partial breast and rectal cancer.

The breast cancer segment, by application, is to register the highest CAGR in the intraoperative radiation therapy market during the forecast period

IORT offers a reduced amount of irradiation, shorter treatment time, and lesser clinical effects on the skin, lung, and heart. Furthermore, in the case of early-stage breast cancer, IORT offers partial breast irradiation and can be used as a breast-conserving alternative to traditional lumpectomy and mastectomy.

North America to dominate the intraoperative radiation therapy market during the forecast period

The North American region is expected to account for the largest share of the intraoperative radiation therapy market. The growth in this market is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of IORT products owing to the increasing incidence of cancer.

Key Market Players

The major players operating in the intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083

iCAD, Inc. is a major player in the intraoperative radiation therapy market. The company offers a wide range of IORT products, including electronic brachytherapy products, different types of applicators, and accessories.